1.
J Fam Pract
; 67(9): 578-579, 2018 09.
Article
En
| MEDLINE
| ID: mdl-30216400
Cognition/drug effects , Dementia/chemically induced , Guidelines as Topic , Hydroxymethylglutaryl-CoA Reductase Inhibitors/standards , Hypercholesterolemia/drug therapy , Pravastatin/standards , Simvastatin/standards , Adult , Aged , Aged, 80 and over , Disease Progression , Female , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Male , Middle Aged , Pravastatin/adverse effects , Pravastatin/therapeutic use , Simvastatin/adverse effects , Simvastatin/therapeutic use , United States , United States Food and Drug Administration